Health Condition 1: null- Epilepsy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of any age and both gender who are willing to give written inform consent. In case of patients less than 18 years of age guardian must be there to provide written inform consent. Patients on Anti-Epileptic treatment with Phenytoin, Carbamazepine or Sodium valproate and in combination therapy with any of these or other Anti-Epileptic drugs for six months or more.
Exclusion criteria
Exclusion criteria: Patients on Anti-Epileptic Drugs for less than six months. Patients on these drugs for indication other than Epilepsy. Patients with history of hepatitis-B OR hepatitis-C Patient who do not give consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To categorize plasma concentration of Anti-Epileptic Drugs according to Sub-therapeutic, Therapeutic, and Toxic concentration.Timepoint: In morning OPD hours and in evening round ( 3days per week)for 1.5 year duration. | — |
Secondary
| Measure | Time frame |
|---|---|
| To correlate plasma concentration with seizure control. To correlate plasma concentration with pill count. To correlate plasma concentration with Adverse Drug Reaction. To find out possible factors for Sub-therapeutic and Toxic concentration. Timepoint: In morning OPD hours and in evening round ( 3days per week)for 1.5 year duration. | — |
Countries
India
Contacts
Government Medical College Bhavnagar